|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01889 SANAI HEALTH GP
Nominal 
0.430 +0.020 (+4.878%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 122,098 | -30.596% | 175,923 | 67,608 | 121,404 | 81,854 |
| Cost of Sales | (86,913) | 3.163% | (84,248) | (27,053) | (90,483) | (79,742) |
| Gross Profit | 35,185 | -61.620% | 91,675 | 40,555 | 30,921 | 2,112 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 2,517 | 638.123% | 341 | -- | -- | (17,465) | |
| Profit / (Loss) on Disposal | -- | -- | (2,484) | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 22,364 | -59.900% | 55,771 | 25,500 | 16,653 | (40,057) | |
| Taxation | (8,997) | -56.270% | (20,574) | (8,625) | (5,161) | 444 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | 148,093 | |
| Non-controlling Interests | 5,266 | -- | (5,980) | (7,850) | (5,070) | 472 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 18,633 | -36.225% | 29,217 | 9,025 | 6,422 | 108,952 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,607 | -6.188% | 1,713 | (712) | (579) | (553) |
| Depreciation & Amortisation | 4,062 | 15.267% | 3,524 | 3,547 | 3,624 | 2,914 |
| Directors' Emoluments | 1,881 | -66.242% | 5,572 | 1,382 | 1,423 | 1,884 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Qualified | -- | Qualified | Qualified | Qualified | Disclaimer |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 14.500 | -38.947% | 23.750 | 7.250 | 5.250 | 87.500 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 2.499 | -- | (0.458) | (0.013) | 0.000 | (0.004) |
| NBV per share ($) | 2.059 | -- | 1.921 | 1.622567 | 1.539626 | 1.467174 |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 9,971,000 |
| %Change | -35.849% |
| EPS / (LPS) | RMB 0.093 |
| NBV Per Share (¥) | RMB 2.129 |